American Society of Hematology, Blood Advances, 24(3), p. 4147-4154, 2019
DOI: 10.1182/bloodadvances.2019000863
Full text: Download
Key Points VWF and FVIII levels after desmopressin, which mimic hemostatic response, are associated with the bleeding phenotype of type 1 VWD patients. Variability in VWF and FVIII response to hemostatic challenges may partly explain heterogeneity in bleeding phenotype of VWD patients.